NIGERIA Work Plan FY 2017 Project Year 6 October 2016‒September 2017 ENVISION is a global project led by RTI International in partnership with CBM International, The Carter Center, Fred Hollows Foundation, Helen Keller International, IMA World Health, Light for the World, Sightsavers, and World Vision. ENVISION is funded by the U.S. Agency for International Development under cooperative agreement No. AID‐OAA‐A‐11‐00048. The period of performance for ENVISION is September 30, 2011 through September 30, 2019. The author’s views expressed in this publication do not necessarily reflect the views of the United States Agency for International Development or the United States Government. ENVISION PROJECT OVERVIEW The U.S. Agency for International Development (USAID)’s ENVISION project (2011‒2019) is designed to support the vision of the World Health Organization (WHO) and its member states by targeting the control and elimination of seven neglected tropical diseases (NTDs), including lymphatic filariasis (LF), onchocerciasis (OV), schistosomiasis (SCH), three soil‐transmitted helminths (STH; roundworm, whipworm, and hookworm), and trachoma. ENVISION’s goal is to strengthen NTD programming at the global and country levels and support Ministries of Health (MOHs) in achieving their NTD control and elimination goals. At the global level, ENVISION—in close coordination and collaboration with WHO, USAID, and other stakeholders—contributes to several technical areas in support of global NTD control and elimination goals, including the following: drug and diagnostics procurement where global donation programs are unavailable capacity strengthening management and implementation of ENVISION’s Technical Assistance Facility disease mapping NTD policy and technical guideline development NTD monitoring and evaluation (M&E). At the country level, ENVISION provides support to national NTD programs by providing strategic technical and financial assistance for a comprehensive package of NTD interventions, including the following: strategic annual and multi‐year planning advocacy social mobilization and health education capacity strengthening baseline disease mapping preventive chemotherapy (PC) or mass drug administration (MDA) drug and commodity supply management and procurement program supervision M&E, including disease‐specific assessments (DSAs) and surveillance. In Nigeria, ENVISION project activities are implemented by The Carter Center and RTI International. ENVISION FY17 PY6 Nigeria Work Plan i TABLE OF CONTENTS Page ENVISION Project Overview ........................................................................................................................... i Acronyms List ............................................................................................................................................... iv Country Overview (narrative format) ........................................................................................................... 1 1) General Country Background ............................................................................................................ 1 a) Administrative Structure ............................................................................................................... 1 b) NTD Program Partners .................................................................................................................. 2 2) National NTD Program Overview ...................................................................................................... 5 a) Lymphatic Filariasis (LF) ................................................................................................................ 5 b) Onchocerciasis (OV) ...................................................................................................................... 6 c) Schistosomiasis (SCH).................................................................................................................... 7 d) Soil‐Transmitted Helminths (STH) ................................................................................................. 7 e) Trachoma ...................................................................................................................................... 8 3) Snapshot of NTD status in Nigeria (Table 2) ..................................................................................... 9 Planned Activities ........................................................................................................................................ 10 1) NTD Program Capacity Strengthening ............................................................................................ 10 a) Strategic Capacity Strengthening Approach ............................................................................... 10 b) Capacity Strengthening Interventions (Table 3) ......................................................................... 11 c) Monitoring Capacity Strengthening ............................................................................................ 12 2) Project Assistance ........................................................................................................................... 14 a) Strategic Planning ....................................................................................................................... 14 b) NTD Secretariat ........................................................................................................................... 16 c) Advocacy for Building a Sustainable National NTD Program ...................................................... 16 d) Social Mobilization to Enable NTD Program Activities ............................................................... 17 e) Training ....................................................................................................................................... 21 f) Mapping ...................................................................................................................................... 26 g) MDA Coverage and Challenges ................................................................................................... 26 h) Drug and Commodity Supply Management and Procurement .................................................. 31 i) Supervision .................................................................................................................................. 32 j) M&E ............................................................................................................................................ 33 3) Maps ............................................................................................................................................... 36 Appendix 1. Work Plan Timeline ................................................................................................................. 40 ENVISION FY17 PY6 Nigeria Work Plan ii Appendix 2. Table of USAID‐supported Provinces/States and Districts ..................................................... 42 LIST OF TABLES Table 1. NTD partners working in country, donor support, and summarized activities ............................... 2 Table 2. Snapshot of the expected status of the NTD program in Nigeria as of July 2016¹ ......................... 9 Table 3. Project assistance for capacity strengthening .............................................................................. 11 Table 4. Social mobilization/communication activities and materials checklist for NTD work planning ... 19 Table 5. Training targets ............................................................................................................................. 22 Table 6. USAID‐supported coverage results for FY15** and targets for FY17 ........................................... 31 Table 7. Planned DSAs for FY17 by disease................................................................................................. 35 ENVISION FY17 PY6 Nigeria Work Plan iii ACRONYMS LIST AE Adverse Event ALB Albendazole APOC African Programme for Onchocerciasis Control CBM Christian Blind Mission CDD Community Drug Distributor CIFF Children’s Investment Fund Foundation CRS Cross River State CS Community Supervisor CST Coverage Supervision Tool CY Calendar Year DFID U.K. Department for International Development DQA Data Quality Assessment DSA Disease‐Specific Assessment END Fund End Neglected Tropical Disease Fund EPIRF PC Epidemiological Data Reporting Form (WHO) EU Evaluation Unit FCT Federal Capital Territory FMOH Federal Ministry of Health FTS Filariasis Test Strip FY Fiscal Year HKI Helen Keller International IEC Information, Education, and Communication IU Implementation Unit IVM Ivermectin JAM Joint Application Matrix (WHO) JRF Joint Request Form (WHO) JRSM Joint Request for Selected PC Medicines (WHO) LF Lymphatic Filariasis LGA Local Government Area LIHT Local Government Integrated Health Team M&E Monitoring and Evaluation MDA Mass Drug Administration MEB Mebendazole Mf Microfilaraemia MITOSATH Mission To Save The Helpless MOE Ministry of Education MOH Ministry of Health NGDO Non‐Governmental Development Organization NOEC National Onchocerciasis Elimination Committee NTD Neglected Tropical Disease OV Onchocerciasis PC Preventive Chemotherapy ENVISION FY17 PY6 Nigeria Work Plan iv PFSA Port Facility Security Assessment PZQ Praziquantel RAPLOA Rapid Assessment Procedure for Loiasis RPA Resident Program Advisor RTI RTI International SAC School‐Aged Children SAFE Surgery–Antibiotics–Face